Subtype
Oropharyngeal Neoplasm
CI-CAN-00003505Explore in graph →
Non-malignant147 active trials2 evidence items
Loading cancer entity…
Subtype
CI-CAN-00003505Explore in graph →
Clinical trials
487 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01855451 | Weekly Cetuximab/RT Versus Weekly Cisplatin/RT in HPV-Associated Oropharyngeal Squamous Cell Carcinoma(HPVOropharynx) | unknown | Phase 3 | 189 | Trans Tasman Radiation Oncology GroupOTHER | 2 | Nov 18, 2022 | clinicaltrials |
| NCT01874171 | Determination of Cetuximab Versus Cisplatin Early and Late Toxicity Events in HPV+ OPSCC(De-ESCALaTE) | unknown | Phase 3 | 334 | University of WarwickOTHER | 3 | May 8, 2017 |
| clinicaltrials |
| NCT00181038 | Analgesia of Fibula Free Flap Donor Site by Peri-Neuronal Catheter in Oro-Pharyngeal Carcinoma Surgery | unknown | Phase 3 | 40 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Aug 28, 2007 | clinicaltrials |
Data updated 22 days agoSource updated Nov 18, 2022source: clinicaltrials